Market Trend Analysis

Context: A leading provider of QA/QC services, including viral clearance validation, wished to identify the optimal emerging technology platforms in which to develop their business, and over what time period. Development candidates included ADCs, cell based therapies and lenti-viral vectors.

Solution: IPAV conducted a strategic review of key market growth indicators for these technological platforms, spanning IP landscaping, academic literature, clinical trial pipelines and stock market performance of publicly traded companies. These multiple factors were used as proxies for technological growth in lieu of the typical ‘finger in the air’ approach of the business development team, the majority of which were only trained in the manufacture of small molecules and filtration of basic biologics.

Outcome: The multiple market indicators were assimilated into a technology growth index that the client has retained IPAV to reproduce and monitor on a regular basis, and they have made what we believe to be an excellent and well-informed strategic decision. Of course, we’re not going to tell you that on our website; however, our Analysts and client continue to enjoy digesting the data and identifying technology trends ahead of their competitors.